Zai Lab Limited ADR [ZLAB] stock is trading at $33.78, up 9.00%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZLAB shares have gain 17.21% over the last week, with a monthly amount glided 26.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on December 14, 2023, when Morgan Stanley initiated its Overweight rating and assigned the stock a price target of $47.50. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on August 10, 2023, and set its price target to $70. On January 21, 2022, Macquarie initiated with a Outperform rating and assigned a price target of $64 on the stock. Bernstein started tracking the stock assigning a Mkt Perform rating. Goldman initiated its recommendation with a Buy. Guggenheim started tracking with a Buy rating for this stock on April 15, 2020, and assigned it a price target of $75. In a note dated July 12, 2019, BofA/Merrill initiated an Buy rating.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $13.48 and $36.60 over the past year. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $33.78 at the most recent close of the market. An investor can expect a potential return of 48.02% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 355.75M for the trailing twelve months, which represents a growth of 47.72%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.95%, Pretax Profit Margin comes in at -0.76%, and Net Profit Margin reading is -0.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.37 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.09 points at the first support level, and at 32.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.73, and for the 2nd resistance point, it is at 35.69.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 3.01. Also, the Quick Ratio is 2.87, while the Cash Ratio stands at 2.15. Considering the valuation of this stock, the price to sales ratio is 10.34, the price to book ratio is 4.98.
Transactions by insiders
Recent insider trading involved Chen Kai-Xian, Director, that happened on Jul 01 ’24 when 7750.0 shares were sold. Amado Rafael completed a deal on Dec 31 ’24 to sell 7583.0 shares. Meanwhile, Officer Amado Rafael bought 7583.0 shares on Dec 31 ’24.
